Novo Genomics
PrivateLast Round
Seed
Apr 1, 2022
Company Overview
Novo Genomics is a biotechnology company that provides genomic and multi-omic laboratory services, including DNA sequencing, genetic screening, and oncology diagnostics, to support clinical diagnostics and personalized healthcare.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novo Genomics Comparables
Compare Novo Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Enigma Genomics | 87% | |
| NoorDx | 86% | |
| AD-Omics | 78% |
Novo Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 1, 2022 |
Key People
Founding team and executive leadership
Novo Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Emkan Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 16, 2026
Monthly visitors increased 493% MoM, reaching 955.
- Sep 26, 2025
Added Propathologyofwy, a pathology startup, as a customer.
Novo Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Novo Genomics's valuation, stock price, and market status.
Is Novo Genomics a public or private company?
Novo Genomics is a private company.
What is the current stock price of Novo Genomics?
Novo Genomics is a private company with no public stock price. No recent secondary market data is available.
How much is Novo Genomics worth (valuation)?
Valuation information for Novo Genomics is not publicly available.
Can I buy Novo Genomics stock?
Novo Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Novo Genomics's last funding round?
Novo Genomics's most recent funding round was Seed on April 1, 2022.
Who are the main investors in Novo Genomics?
Key investors in Novo Genomics include Emkan Capital.
Will Novo Genomics IPO soon?
No public IPO plans have been announced for Novo Genomics.
How can I track Novo Genomics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Novo Genomics's secondary market activity and sign up for updates.